For many years, the country has witnessed funding decisions from Department of Biotechnology (DBT), the premier national funding agency, without a vision document in place. A draft for biotechnology policy was hurriedly framed recently in two swift meetings of the Expert Committee constituted for the purpose; one was the inaugural meeting, followed by another meeting. There was one or the other sub committee meeting in addition. Surprisingly, no minutes of the meetings were circulated to the members of Expert Committee and suddenly the draft “National Biotechnology Development Strategy” appeared on the DBT website with a stipulated 6 week period for comments.

doi : 10.5214/ans.0972.7531.2009.160102